Viewing nowLosardin Tablet 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 201907866 · Approved 2019.11.12 · Insurance code 628902290
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension. It is particularly helpful in preventing and treating kidney disease in patients with hypertension and type 2 diabetes. It is used to effectively manage hypertension, reduce the risk of cardiovascular complications, and prevent kidney function deterioration.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses per day or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular effective blood volume For patients who may have reduced intravascular effective blood volume (intravascular volume depletion) (e.g., patients receiving treatment with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication may cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, and should not be taken by women who are pregnant or may become pregnant. If pregnancy is confirmed, the medication should be discontinued immediately, as it may affect the health of the fetus and newborn. This medication should not be administered to patients with certain liver diseases, hereditary angioedema, or primary hyperaldosteronism, nor should it be taken by patients with lactose intolerance. Extra caution should be exercised when administering this medication to the elderly, patients with impaired kidney function, or those with hyperkalemia, as there is a risk of a sudden drop in blood pressure. Common side effects that may occur during treatment include dizziness, headache, cough, muscle pain, and others, and if abnormal symptoms persist, a doctor should be consulted. Additionally, this medication may cause more severe side effects when taken in conjunction with other antihypertensives, potassium supplements, or certain diuretics, so it should only be taken after consulting with a healthcare provider. It is preferable for pregnant or breastfeeding women not to take this medication, and if it must be taken, breastfeeding should be discontinued. It has not been confirmed to be safe for children, particularly those under 6 years old or those with severely impaired kidney function. During treatment, it is important to regularly check blood pressure, kidney function, and potassium levels in the blood for any abnormalities. In case of overdose, symptoms such as hypotension and bradycardia may occur, requiring immediate medical attention. This medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best kept at room temperature, between 1 and 30 degrees Celsius, avoiding extreme heat or cold. This storage method helps maintain the medication's effectiveness for a longer period.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.